Knight Therapeutics Inc.
KHTRF
$5.32
$0.030.57%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 83.31M | 84.82M | 85.36M | 111.31M | 120.12M |
| Total Receivables | 100.82M | 93.43M | 78.97M | 101.85M | 78.91M |
| Inventory | 99.09M | 103.67M | 108.99M | 97.51M | 71.38M |
| Prepaid Expenses | 4.74M | 5.75M | 5.39M | 5.19M | 5.38M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 287.97M | 287.67M | 278.71M | 315.86M | 275.79M |
|
|
|||||
| Total Current Assets | 287.97M | 287.67M | 278.71M | 315.86M | 275.79M |
| Net Property, Plant & Equipment | 15.99M | 15.64M | 15.00M | 14.59M | 13.92M |
| Long-term Investments | 65.63M | 66.22M | 66.59M | 62.63M | 60.10M |
| Goodwill | 65.63M | 66.22M | 66.59M | 62.63M | 60.10M |
| Total Other Intangibles | 276.79M | 270.96M | 281.61M | 189.97M | 197.11M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 58.76M | 60.69M | 61.96M | 53.91M | 51.05M |
| Total Assets | 763.10M | 752.81M | 761.03M | 697.84M | 669.84M |
|
|
|||||
| Total Accounts Payable | 88.15M | 81.02M | 76.94M | 81.92M | 54.45M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 135.70K | -- | 2.11M | -- | 1.47M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.54M | 15.46M | 14.18M | 16.84M | 12.52M |
| Total Finance Division Other Current Liabilities | 17.70M | 13.13M | 19.65M | 7.41M | 8.88M |
| Total Other Current Liabilities | 17.70M | 13.13M | 19.65M | 7.41M | 8.88M |
| Total Current Liabilities | 120.53M | 109.61M | 112.88M | 106.18M | 77.32M |
|
|
|||||
| Total Current Liabilities | 120.53M | 109.61M | 112.88M | 106.18M | 77.32M |
| Long-Term Debt | 37.32M | 56.53M | 57.81M | 18.32M | 18.00M |
| Short-term Debt | 135.70K | -- | 2.11M | -- | 1.47M |
| Capital Leases | 4.83M | 4.28M | 2.70M | 2.35M | 2.39M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 40.83M | 31.88M | 28.16M | 17.59M | 19.54M |
| Total Liabilities | 203.50M | 202.30M | 201.55M | 144.44M | 117.24M |
|
|
|||||
| Common Stock & APIC | 410.31M | 403.70M | 410.99M | 388.13M | 389.18M |
| Retained Earnings | 108.63M | 100.81M | 105.74M | 109.09M | 107.58M |
| Treasury Stock & Other | 40.65M | 45.99M | 42.76M | 56.18M | 55.83M |
| Total Common Equity | 559.60M | 550.50M | 559.48M | 553.41M | 552.60M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 559.60M | 550.50M | 559.48M | 553.41M | 552.60M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 559.60M | 550.50M | 559.48M | 553.41M | 552.60M |
|
|
|||||